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E-mail address: caiminxu@yahoo.com.cn (C. Xu).Following our previous ﬁnding that sodium selenite induces apoptosis in human leukemia NB4
cells, we now show that the expression of the critical antioxidant enzyme manganese superoxide
dismutase (MnSOD) is remarkably elevated during this process. We further reveal that reactive oxy-
gen species (ROS), especially superoxide radicals, play a crucial role in selenite-induced MnSOD
upregulation, with extracellular regulated kinase (ERK) and p53 closely implicated. Speciﬁcally,
ERK2 translocates into the nucleus driven by ROS, where it directly phosphorylates p53, leading
to dissociation of p53 from its inhibitory protein mouse double minute 2 (MDM2). Active p53
directly mediates the expression of MnSOD, serving as the link between ERK2 translocation and
MnSOD upregulation.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Selenium is one of the essential trace elements with anti-tumor
properties. Supranutritional selenium compounds are able to trig-
ger apoptosis in diverse tumor cell lines [1–3]. In our previous
work, we found 20 lmol/l of sodium selenite-induced pronounced
apoptosis in NB4 cells derived from human acute promyelocytic
leukemia (APL), while reactive oxygen species (ROS) played a crit-
ical role [4–9]. Here we discovered dramatically elevated expres-
sion of manganese superoxide dismutase (MnSOD) during this
process. Mainly located in mitochondrial matrix, MnSOD is well
known as one of the major antioxidant enzymes against superox-
ide free radicals, and catalyzes dismutation of superoxide radical
anion into hydrogen peroxide, protecting cells from damage of oxi-
dative stress [10,11]. Therefore MnSOD upregulation seems an
important protective mechanism by which NB4 cells counteracts
ROS-mediated injuries.
As to the detailed mechanisms of MnSOD upregulation, we elu-
cidated that extracellular regulated kinase (ERK) and p53 were clo-
sely involved. ERK participates in a variety of cellular activities
including proliferation, differentiation, cycle progression, aging,chemical Societies. Published by E
; MnSOD, manganese super-
xtracellular regulated kinase;migration, cytoskeleton formation as well as apoptosis by phos-
phorylating extensive target proteins. ERK2 and ERK1 are predom-
inant members of this family with highly similar structures and
functions [12,13]. ERK is capable of entering the nucleus to exert
the functions of cell death repression and cell cycle entry [14–
17]. As another important factor, p53 is known as one of the most
crucial tumor suppressors with the ability to block cell cycle, initi-
ate DNA repair, accelerate cell aging and induce apoptosis [18].
Also, as a transcription factor, p53 regulates a series of target genes
including sod2 which encodes MnSOD [19,20]. According to the
previous research [21–24], as well as the data from our cDNA
sequencing analysis, NB4 cells express a wild-type p53. Here we
demonstrated that ERK2 was translocated into the nucleus driven
by ROS, where it directly bound to and phosphorylated p53 at
the vital site Ser15. Consequently, p53 dissociated from its inhibi-
tory protein mouse double minute 2 (MDM2) and contributed to
augmented expression of MnSOD. Additionally, in leukemia cell
lines with null or mutant p53 such as HL-60 and U937, selenite
could not induce the upregulation of MnSOD, further corroborating
the critical role of p53 in this modulation.
2. Materials and methods
2.1. Cell culture
NB4, HL-60 and U937 cells were cultured in RPMI 1640 culture
medium (Gibco, USA) supplemented with 10% fetal bovine serum,lsevier B.V. All rights reserved.
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streptomycin in a humidiﬁed 5% CO2 atmosphere at 37 C.
2.2. Reagents and antibodies
Sodium selenite (purity 98%) was purchased from Sigma–
Aldrich (St. Louis, MO, USA). Antibody to MnSOD was purchased
from BD Transduction Laboratories (Lexington, KY, USA). Antibod-
ies to ERK2, B23, MDM2 and Bax were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Antibodies to phospho-ERK1/
2 (Thr202/Tyr204), p53 and phospho-p53 (Ser15) were purchased
from Cell Signaling Technology (Danvers, MA, USA). Antibody to b-
actin was purchased from Sigma–Aldrich. The chemical inhibitors
SB203580, SP600125 and PD98059 were purchased from Promega
(Madison, WI, USA). MnTMPyP and Piﬁthrin-a were purchased
from Calbiochem (San Diego, CA, USA).
2.3. Cell lysis and Western blot analysis
About 1  107 cells were collected and washed twice with ice-
cold PBS. The harvested cells were lysed in cell lysis buffer RIPA
(20 mM Tris pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1%
Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM b-glycerol-
phosphate, 1 mM Na3VO4, 1 lg/ml leupeptin, 1 mM PMSF) and
subjected to sonication for 30 s. The cell lysates were centrifuged
at 12 000g for 25 min at 4 C and the supernatant was collected.
Bradford Assay was used to determine the protein concentration.
After normalized, equal amounts of proteins were subjected to
15% SDS–PAGE and transferred to nitrocellulose membranes. The
membranes were blocked with 5% non-fat milk in TBST and incu-
bated with primary antibodies at 4 C overnight. After washed with
TBST, membranes were incubated with HRP-conjugated secondary
antibodies for 90 min at room temperature. After a second washing
with TBST, the blots were probed with SuperSignal Chemilumines-
cent substrate (Thermo Scientiﬁc, USA) to visualize the immunore-
active bands.
2.4. p53 cDNA sequencing
Total RNA of NB4 cells was extracted using Trizol reagents
(Invitrogen, CA, USA). Then RNA was reverse-transcribed into
cDNA using M-MLV reverse transcriptase (Promega). Three pairs
of primers were used to cover the whole protein coding region of
p53 cDNA. Fragment 1: 50-GGG GAC ACT TTG CGT TCG-30 and 50-
TGA CTG CTT GTA GAT GGC-30, 591 bp product, covering entire
exon 2–4 and parts of exon 1 and 5. Fragment 2: 50-TTC CGT CTG
GGC TTC TTG-30 and 50-TGG GCA TCC TTG AGT TCC-30, 737 bp prod-
uct, covering entire exon 5–9 and parts of exon 4 and 10. Fragment
3: 50-CGG CGC ACA GAG GAA GAG AAT C-30 and 50-CGC ACA CCT
ATT GCA AGC AAG GG-30, 445 bp product, covering entire exon
9–10 and parts of exon 8 and 11. cDNA samples were subjected
to PCR ampliﬁcation using La Taq Polymerase (Takara Biotechnol-
ogy, Dalian, China) with the following conditions: denaturation
at 94 C for 10 min, 30 cycles each including denaturation at
94 C for 30 s, annealing at 55 C for 30 s and extension at 72 C
for 1 min, followed by a ﬁnal extension at 72 C for 10 min. The
PCR products were sequenced by Invitrogen (Shanghai, China).
2.5. Extraction of cytoplasmic and nuclear fractions
About 1  107 cells were collected and washed twice with ice-
cold PBS. The harvested cells were lysed in nuclear protein extrac-
tion buffer A (Boster Biological Technology, Wuhan, China) on ice
for 30 min. Then the cell lysates were centrifuged at 12 000g
for 10 min at 4 C and the supernatant was collected as the cyto-
plasmic fractions. The pellet was lysed in nuclear protein extrac-tion buffer B (Boster Biological Technology) on ice for 30 min.
Then the lysates were centrifuged at 12 000g for 10 min at 4 C
and the supernatant was collected as the nuclear fractions. PMSF
and leupeptin were added into buffer A and buffer B before use.
2.6. Immunoﬂuorescent staining
About 1  106 cells were collected and washed twice with ice-
cold PBS. The harvested cells were transferred to slides, ﬁxed in
freshly prepared 4% formaldehyde for 10 min, subjected to perme-
abilization with 1% Triton X-100 for 30 min. Then the cells were
incubated with primary antibody (1:50 dilution) at 4 C overnight
and TRITC conjugated goat anti-rabbit IgG or FITC conjugated goat
anti-mouse IgG (1:50 dilution) for 1 h at room temperature. After
washed with PBS, cells were stained with DAPI (Sigma–Aldrich)
for 5 min. Then the slides were mounted with Fluo-antifading
medium (Genmed, Shanghai, China). Image observation and cap-
ture were immediately performed using a TE2000-U Nikon Eclipse
microscope (Nikon, Tokyo, Japan).
2.7. Immunoprecipitation
Nuclear fractions were extracted as described above. Bradford
Assay was used to determine the protein concentration. Sufﬁcient
amount of p53 antibody was added into 200 lg proteins and gently
rotated at 4 C overnight. The immunocomplex was captured by
adding 25 ll protein A+G agarose beads (Beyotime, Jiangsu, China)
and gently rotating at 4 C for 3 h. Then the mixture was centri-
fuged at 1500g for 5 min at 4 C and the supernatant was dis-
carded. The precipitate was washed for three times with ice-cold
RIPA buffer, resuspended in 3 sample buffer and boiled for
5 min to dissociate the immunocomplex from the beads. The
supernatant was collected by centrifugation and subjected to Wes-
tern blot (8% SDS–PAGE).
2.8. siRNA transfection
The small interference RNA (siRNA) targeting p53 (50-CUACU
UCCUG AAAAC AACGTT-30) [25] and non-silencing scrambled siR-
NA were synthesized by GenePharma (Shanghai, China). About
3  106 cells were collected and washed with serum-free grow
medium without antibiotics. Then the cells were transfected with
100 or 200 nmol/l siRNA using Opti-MEM reduced serum medium
(Gibco) and DMRIE-C reagent (Invitrogen). A subsequent transfec-
tion after 24 h was performed to promote p53 inhibition. Then
cells were treated with 20 lmol/l sodium selenite for 24 h.
2.9. Flow cytometric analysis of cell apoptosis using Annexin V-FITC/PI
staining
The detection was performed according to the manual of An-
nexin V-FITC apoptosis detection kit (Calbiochem). About 1  106
cells were collected, washed with ice-cold PBS, and resuspended
in the binding buffer containing suitable amount of Annexin V-
FITC. Cells were incubated in the dark for 15 min at room temper-
ature, then the buffer was removed by centrifugation. The cells
were resuspended in the binding buffer containing propidium io-
dide (PI). Then ﬂow cytometric analysis was immediately per-
formed to detect apoptosis.
2.10. ROS measurement
About 3  105 cells were harvested, washed with serum-free
RPMI culture medium and incubated with 5 lmol/l dichloroﬂuo-
rescein diacetate (DCFH-DA, Beyotime) or dihydroethidium (DHE,
Beyotime) at 37 C for 30 min. Then the cells were harvested,
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or without 20 lmol/l sodium selenite. DCF or DHE ﬂuorescence
distribution was recorded each hour by a ﬂuorospectrophotometer
for up to 20 h (DCF: excitation wavelength 488 nm and emission
wavelength 535 nm, DHE: excitation wavelength 325 nm and
emission wavelength 610 nm).
2.11. Statistical analysis
Data were analyzed by two-tailed student’s t-test. A value of
P < 0.05 was considered statistically signiﬁcant.
3. Results
3.1. MnSOD was upregulated through ROS in selenite-induced
apoptosis and ERK was involved in this upregulation
Apparent apoptosis of NB4 cells induced by 20 lmol/l of sodium
selenite was indicated by Annexin V-FITC/PI staining (Fig. 1A). Dur-
ing this process, two intracellular ROS, superoxide and hydrogen
peroxide were detected by dihydroethidium (DHE) and dichloro-
hydroﬂuorescein (DCF) assay respectively. The results demon-
strated that both of them were notably increased shortly after
selenite exposure, but the superoxide radicals declined obviously
after 12 h, whereas the hydrogen peroxide maintained a relatively
high level (Fig. 1B). In addition, expression of MnSOD, was induced
in both dose-dependent (Fig. 1C) and time-dependent (Fig. 1D)
manners, suggesting a protective mechanism initiated by NB4 cells
against oxidative stress. Notably, after the depletion of ROS by the
cell-permeable ROS scavenger MnTMPyP, elevated expression of
MnSOD dismissed completely (Fig. 1E and F), indicating a key role
of ROS in MnSOD upregulation. Speciﬁcally, to substantiate
whether the various critical kinases were implicated in MnSOD
upregulation, different selective kinase inhibitors were used. Prior
to selenite exposure, cells were pretreated with SB203580,
SP600125 and PD98059, which speciﬁcally inhibited p38MAPK,
JNK and ERK respectively. The results showed that SB203580 andFig. 1. MnSOD was upregulated through ROS in selenite-induced apoptosis. (A) Sodium s
(20 lmol/l) for different time as indicated. Then apoptosis was analyzed by ﬂow cytome
(n = 3), *P < 0.05 compared with control group. (B) Selenite-induced ROS generation. NB
hydrogen peroxide was detected by DHE or DCF-based measurements respectively. D
upregulation in a dose-dependent manner. Cells were treated with different doses of sele
induced MnSOD upregulation in a time-dependent manner. Cells were treated with seleni
blot. (E) Effect of ROS scavenger on MnSOD upregulation at 24 h. Cells were pretreated w
24 h. Then MnSOD was detected byWestern blot. (E) Effect of ROS scavenger on MnSOD u
l) for 1 h before selenite (20 lmol/l) exposure for different time as indicated. Then Mn
separate experiments.SP600125 had no obvious effects on selenite-induced MnSOD
expression (Supplementary Fig. 1A), while PD98059 entirely re-
versed it (Supplementary Fig. 1B and C), indicating a signiﬁcant
regulatory role of ERK.
3.2. Selenite-induced nuclear translocation of ERK2 through ROS
To deﬁne the detailed role of ERK in MnSOD upregulation, we
extracted cytoplasmic and nuclear fractions of NB4 cells, and de-
tected distribution of ERK2 between these two compartments. A
remarkable translocation of total ERK2 and the active form phos-
phorylated ERK1/2 into the nucleus from the cytoplasm was ob-
served since an early stage (Fig. 2A). Such translocation was
entirely abrogated by ROS scavenger MnTMPyP (Fig. 2B and C),
indicating the driving force of ROS. This was further conﬁrmed
by immunoﬂuorescent staining, through the co-localization of
ERK2 and DAPI in the merged image after selenite exposure, which
was completely cancelled by MnTMPyP (Fig. 2D). Considering the
critical function of ERK for MnSOD upregulation and the impor-
tance of nucleus for regulating protein expression, we hypothe-
sized that the nuclear translocation of ERK2 was probably a
critical process closely related with MnSOD upregulation.
3.3. ERK2 phosphorylated and activated nuclear p53 after its
translocation
We inferred from the results described above that there must be
some links between ERK2 translocation and MnSOD upregulation.
Since p53 is an transcription factor regulating MnSOD expression,
and p53 phosphorylation is indicative of its functional activation
[26–29], we proposed a possibility that p53 acted as a key factor.
To conﬁrm this, ﬁrst we identiﬁed the p53 status by cDNA
sequencing. The results showed that a wild-type p53 was ex-
pressed in the NB4 cells used in this study (data not shown). Then
we extracted nuclear fractions of cells and detected the phosphor-
ylation level of p53 (Ser15). Obviously, p53 phosphorylation was
stimulated by selenite since 6 h and peaked at 9 h, while totalelenite-induced apoptosis of NB4 cells. NB4 cells were treated with sodium selenite
try using Annexin V-FITC/PI staining. Data were presented as mean values with SD
4 cells were treated with sodium selenite (20 lmol/l). Intracellular superoxide or
ata were presented as mean values with SD (n = 3). (C) Selenite-induced MnSOD
nite as indicated for 24 h. Then MnSOD was detected by Western blot. (D) Selenite-
te (20 lmol/l) for different time as indicated. Then MnSOD was detected byWestern
ith or without MnTMPyP (10 lmol/l) for 1h before selenite (20 lmol/l) exposure for
pregulation at different time points. Cells were pretreated with MnTMPyP (10 lmol/
SOD was detected by Western blot. The data were representative of at least three
Fig. 2. Selenite-induced nuclear translocation of ERK2 through ROS. (A) Nuclear translocation of ERK2 induced by selenite. Cells were treated with selenite (20 lmol/l) for
different time as indicated. Then cytoplasmic and nuclear fractions were extracted and ERK2 as well as p-ERK1/2 (Thr202/Tyr204) were detected byWestern blot. b-actin and
B23 were used as loading control of cytoplasmic and nuclear proteins respectively. (B) Effect of ROS scavenger on ERK2 translocation at 12 h. Cells were pretreated with or
without MnTMPyP (10 lmol/l) for 1 h before selenite (20 lmol/l) exposure for 12 h. Then cytoplasmic and nuclear fractions were extracted and ERK2 was detected by
Western blot. (C) Effect of ROS scavenger on ERK2 translocation at different time points. Cells were pretreated with or without MnTMPyP (10 lmol/l) for 1h before selenite
(20 lmol/l) exposure for different time as indicated. Then cytoplasmic and nuclear fractions were extracted and ERK2 as well as p-ERK1/2 (Thr202/Tyr204) were detected by
Western blot. (D) Nuclear translocation of ERK2 demonstrated by immunoﬂuorescent staining. Cells were pretreated with or without MnTMPyP (10 lmol/l) for 1h before
selenite (20 lmol/l) exposure for 12 h, then ERK2 was immunostained with its primary antibody and TRITC conjugated secondary antibody (red). The nucleus was labeled
with DAPI (blue). The data were representative of at least three separate experiments.
Fig. 3. ERK2 phosphorylated and activated nuclear p53 after its translocation. (A) Phosphorylation of nuclear p53 (Ser15) induced by selenite. Cells were treated with selenite
(20 lmol/l) for different time as indicated before nuclear fractions were extracted. Then p-p53 (Ser15) and total p53 were detected by Western blot. B23 was used as loading
control of nuclear proteins. (B) Effect of ERK inhibitor on nuclear p53 phosphorylation at 9 h. Cells were pretreated with or without PD98059 (20 lmol/l) for 1.5 h before
selenite (20 lmol/l) exposure for 9 h. Then nuclear fractions were extracted. p-p53 (Ser15) and total p53 were detected by Western blot. (C) Effect of ERK inhibitor on nuclear
p53 phosphorylation at different time points. Cells were pretreated with or without PD98059 (20 lmol/l) for 1.5 h before selenite (20 lmol/l) exposure for different time as
indicated. Then nuclear fractions were extracted. p-p53 (Ser15) and total p53 were detected by Western blot. (D) Phosphorylation of p53 demonstrated by
immunoﬂuorescent staining. Cells were pretreated with or without PD98059 (20 lmol/l) for 1.5 h before selenite (20 lmol/l) exposure for 9 h, then p-p53 (Ser15) was
immunostained with its primary antibody and FITC conjugated secondary antibody (green). The nucleus was labeled with DAPI (blue). (E) Interactions of p53 with ERK2 and
MDM2 in the nucleus. Cells were treated with selenite (20 lmol/l) for different time as indicated. Then nuclear fractions were extracted and immunoprecipitated with p53
antibody, after which p53, ERK2 and MDM2 in the immunoprecipitated products were detected by Western blot. IP: immunoprecipitation, WB: Western blot. The data were
representative of at least three separate experiments.
2294 Z. Li et al. / FEBS Letters 584 (2010) 2291–2297
Fig. 4. Active p53 mediated upregulation of MnSOD. (A) Effect of p53 inhibitor on MnSOD upregulation at 24 h. Cells were pretreated with or without Piﬁthrin-a (PFT,
100 lmol/l) for 1.5 h before selenite (20 lmol/l) exposure for 24 h. Then MnSOD was detected by Western blot. (B) Effect of p53 inhibitor on MnSOD upregulation at different
time points. Cells were pretreated with or without Piﬁthrin-a (100 lmol/l) for 1.5 h before selenite (20 lmol/l) exposure for different time as indicated. Then MnSOD was
detected by Western blot. (C) Effect of p53 RNA interference on MnSOD and Bax expression. Cells were transfected twice with different doses of p53 siRNA or non-silencing
scrambled siRNA respectively, followed by selenite (20 lmol/l) exposure for 24 h. Then MnSOD and Bax were detected by Western blot. (D) Effect of selenite on MnSOD
expression in HL-60 and U937 cells. HL-60 or U937 Cells were treated with different doses of selenite as indicated for 24 h. Then MnSOD was detected by Western blot. The
data were representative of at least three separate experiments.
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thoroughly abolished by ERK inhibitor PD98059 (Fig. 3B and C),
indicating ERK was responsible for this regulation. The participa-
tion of ERK in p53 phosphorylation was also demonstrated by
immunoﬂuorescent staining (Fig. 3D). Subsequently we performed
immunoprecipitation of nuclear fractions with p53 antibody and
detected p53 interactions with relative proteins. The results made
clear an increased interaction between p53 and ERK2 as well as a
contrary trend between p53 and MDM2 in the nucleus after sele-
nite exposure (Fig. 3E), reﬂecting dissociation of p53 from MDM2
following association of p53 with ERK2.3.4. Active p53 mediated upregulation of MnSOD
Then we explored whether the active p53 was involved in sele-
nite-induced MnSOD upregulation. Piﬁthrin-a, a selective inhibitor
for p53 was used to pretreat the cells before selenite exposure, and
MnSOD upregulation was notably attenuated by this treatment
(Fig. 4A and B). Likewise, p53 expression was inhibited by RNA
interference, after which selenite-induced expression of MnSOD
was weakened as well (Fig. 4C). In addition, bax, one of the p53-
targeted genes, was also upregulated by selenite, which was
blocked by p53 interference too (Fig. 4C), suggesting p53 exerted
its transcriptional activity. Moreover, two other leukemia cell lines
with different status of p53 were applied in this study. The HL-60
cell line has been deﬁnitely conﬁrmed to lack p53 due to a major
gene deletion [30–32], while the U937 cell line carries a mutant,
inactive p53 resulted from deletion of 46 bases in p53 gene
[33,34]. When treated with various doses of selenite, HL-60 and
U937 cells showed no elevation of MnSOD (Fig. 4D), demonstrating
that functional p53 is indispensable for selenite-induced MnSOD
augment.4. Discussion
It is shown by growing evidence that tumor cells and normal
cells have different sensitivities to selenite treatment [35,36]. Our
previous research has revealed apoptosis induced by selenite in
leukemia-derived NB4 cells and colorectal cancer-derived SW480cells. Moreover, our in vivo experiments indicated selenite inhib-
ited colorectal tumor growth in mice without obvious adverse ef-
fects on body weights and activities [37], which is an
encouraging ﬁnding suggesting selenite may ﬁnd its way in the
treatment of human tumors. Undoubtedly, before selenite can be
safely applied to humans, some problems must be settled such as
the appropriate dose and metabolic mechanisms in human body
inﬂuencing its cellular effects.
Here in the present study, we found two intracellular ROS,
superoxide and hydrogen peroxide were elevated immediately fol-
lowing selenite exposure. As a critical antioxidant enzyme remov-
ing superoxide free radicals, MnSOD remarkably increased during
this process. MnSOD played a quite essential role in detoxiﬁcation
of the injurious ROS. Loss of MnSOD will result in serious events as
aggravated endogenous oxidative stress or apoptosis [38,39],
whereas its overexpression inhibits proline oxidase or radiation-
induced apoptosis [40,41]. Therefore we postulated that upregula-
tion of MnSOD presumably was a protective mechanism of NB4
cells under formidable threats of ROS. Previously we have already
illuminated the vital role of ROS in selenite-induced apoptosis
[4,6]. In this study, MnTMPyP totally reversed MnSOD upregula-
tion, indicating ROS was also involved in the augment of MnSOD.
Since MnTMPyP mainly targets superoxide radicals, we infer that
superoxide, instead of hydrogen peroxide, is the most probable
ROS responsible for selenite-induced apoptosis and MnSOD upreg-
ulation. Here as shown in Fig. 1B, the superoxide generation in NB4
cells was elevated immediately following selenite treatment, and
peaked at approximately 12 h, after which it declined swiftly. Be-
cause MnSOD protein level started to increase since 12 h as shown
in Fig. 1E, and its expression was reported to prohibit generation of
superoxide radicals [42,43], it is reasonable to conclude that
MnSOD upregulation, at least partially, participated in the decrease
of superoxide level after 12 h. Therefore we hypothesize that a
feedback relationship exists between MnSOD and ROS, especially
the superoxide radicals. Selenite induced substantial superoxide
generation in NB4 cells. As a result, superoxide caused upregula-
tion of MnSOD, which removed the former in return.
As to the detailed mechanism how ROS mediated MnSOD
upregulation, we found ERK played a signiﬁcant role. ERK2 was
translocated into the nucleus under the regulation of ROS,
2296 Z. Li et al. / FEBS Letters 584 (2010) 2291–2297therefore we infer ERK2 probably entered the nucleus to phosphor-
ylate and activate one or more transcription factors targeting
MnSOD gene. As a vital tumor suppressor, p53 exerted its anti-
tumor effects mainly by transactivation of diverse target genes
including Bax, Apaf-1 and caspase-6, or mitochondrial transloca-
tion to induce apoptosis independent of its transactivation ability
[18,44,45]. As a target of p53, sod2 gene encoding MnSOD contains
binding sites for p53 in the promoter, and its expression can be
induced by p53 under certain stimuli such as doxorubicin treat-
ment [19,20]. Although p53 is found mutated or depleted in vari-
ous tumor cells, NB4 cells express a wild-type p53 conﬁrmed by
our cDNA sequencing analysis. Here we observed pronounced
phosphorylation of nuclear p53 at Ser15 after selenite treatment,
which was totally eliminated by ERK inhibitor. In addition, amount
of total nuclear p53 was unaltered, thus ruling out nuclear translo-
cation of p53 from the cytoplasm. Collectively, these results
indicated that by virtue of nuclear translocation, ERK2 phosphory-
lated p53 in the nucleus. It has been validated p53 phosphorylation
at Ser15 inhibits its interaction with the negative regulator MDM2,
the product of an oncogene. Binding of MDM2 to p53 prohibits
transactivation ability of p53 and targets p53 for proteasome-med-
iated degradation. Phosphorylation at Ser15 releases p53 from
MDM2, promoting accumulation, DNA-binding property and func-
tional activation of p53 [26–29]. Therefore, activation of nuclear
p53 can be regarded as a signiﬁcant consequence of ERK2 translo-
cation. Moreover, immunoprecipitation of nuclear fractions
revealed increased interaction between p53 and ERK2, as well as
decreased interaction between p53 and MDM2 in response to
selenite. We conclude from these results that without stimulus of
selenite, nuclear p53 was associated with its inhibitory protein
MDM2 and thus remained an inactive status. After selenite expo-
sure, ERK2 entered the nucleus and phosphorylated p53 by direct
contact, followed by the dissociation of p53 from MDM2, contrib-
uting to p53 activation.
To elucidate whether p53 was indeed involved in MnSOD
upregulation, we used Piﬁthrin-a (PFT), a selective p53 inhibitor
which blocks p53-dependent transactivation [46], as well as p53
siRNA interference. Both treatment attenuated selenite-induced
MnSOD upregulation, indicating the role of p53 to facilitate
MnSOD expression. We also noticed that in the leukemia cell lines
with null or mutant p53 such as HL-60 and U937, selenite could
not induce MnSOD elevation as in NB4 cells, substantiating the
key role of functional p53 in selenite-induced MnSOD upregula-
tion. In summary, p53 activation can be considered as the link con-
necting ERK2 translocation and MnSOD upregulation. Triggered by
ROS, ERK2 was translocated from the cytoplasm into the nucleus,
where it directly interacted with and phosphorylated p53 at
Ser15. As a result, p53 dissociated from MDM2 and was activated
to induce MnSOD upregulation, representing a possible protective
mechanism of NB4 cells to counteract oxidative stress (Supple-
mentary Fig. 2).
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